Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
14 Febbraio 2025 - 10:05PM
Edgar (US Regulatory)
Exhibit
1
JOINT
FILING AGREEMENT
The
undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned, and that
all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity
of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of
such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible
for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe
that such information is inaccurate.
| Dated: February 14, 2025 |
|
| |
|
| Commodore Capital LP |
|
| |
|
|
| By: |
/s/ Michael
Kramarz |
|
| Michael Kramarz, Managing Partner |
|
| |
|
|
| Commodore Capital Master LP |
|
| |
|
|
| By: |
/s/ Michael
Kramarz |
|
| Michael Kramarz, Authorized Signatory |
|
Grafico Azioni Nurix Therapeutics (NASDAQ:NRIX)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Nurix Therapeutics (NASDAQ:NRIX)
Storico
Da Feb 2024 a Feb 2025
